The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Spangler Jonathan since year 2005.
The trader's CIK number is 1312160.
At the time of this reporting, Spangler Jonathan is the Chief Patent Counsel of
Nuvasive Inc
(stock ticker symbol NUVA).
Stock purchases, sales, and option exercises reported by Spangler Jonathan since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2006-12-28
NUVA
Nuvasive Inc
Option Exercise
8,500
.63
5,355
2006-12-28
NUVA
Nuvasive Inc
Sale
8,500
23.65
201,067
2006-11-28
NUVA
Nuvasive Inc
Sale
1,000
21.84
21,837
2006-11-28
NUVA
Nuvasive Inc
Option Exercise
1,000
.63
630
2006-10-26
NUVA
Nuvasive Inc
Option Exercise
1,000
.63
630
2006-10-26
NUVA
Nuvasive Inc
Sale
1,000
24.07
24,074
2006-09-28
NUVA
Nuvasive Inc
Sale
1,000
20.67
20,670
2006-09-28
NUVA
Nuvasive Inc
Option Exercise
1,000
.63
630
2006-08-25
NUVA
Nuvasive Inc
Option Exercise
1,000
.63
630
2006-08-25
NUVA
Nuvasive Inc
Sale
1,000
18.74
18,735
2006-07-28
NUVA
Nuvasive Inc
Option Exercise
6,000
.63
3,780
2006-07-28
NUVA
Nuvasive Inc
Sale
6,000
17.20
103,216
2006-06-27
NUVA
Nuvasive Inc
Option Exercise
15,000
.63
9,450
2006-06-27
NUVA
Nuvasive Inc
Sale
15,000
17.46
261,849
2006-02-28
NUVA
Nuvasive Inc
Sale
1,500
18.58
27,867
2006-01-30
NUVA
Nuvasive Inc
Sale
1,500
17.96
26,932
2005-12-28
NUVA
Nuvasive Inc
Sale
1,500
18.14
27,214
2005-11-28
NUVA
Nuvasive Inc
Sale
1,500
17.12
25,672
2005-10-27
NUVA
Nuvasive Inc
Sale
1,500
18.67
28,006
2005-09-28
NUVA
Nuvasive Inc
Sale
1,500
18.03
27,045
2005-08-25
NUVA
Nuvasive Inc
Sale
1,500
19.22
28,830
2005-07-28
NUVA
Nuvasive Inc
Sale
1,500
19.26
28,890
2005-06-27
NUVA
Nuvasive Inc
Sale
1,500
17.06
25,589
2005-05-26
NUVA
Nuvasive Inc
Sale
1,500
15.05
22,575
2005-04-27
NUVA
Nuvasive Inc
Sale
1,500
13.90
20,850
2005-03-28
NUVA
Nuvasive Inc
Sale
7,500
12.45
93,382
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Spangler Jonathan
(Chief Patent Counsel of Nuvasive Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
